Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies
References (61)
- et al.
Migraine prevalence, disease burden, and the need for preventive therapy
Neurology
(2007) - et al.
The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity
Cephalalgia
(2003) - et al.
Epidemiology of headache in Europe
Eur j Neurol
(2006) - et al.
Cumulative lifetime migraine incidence in women and men
Cephalalgia
(2008) - et al.
The global burden of migraine: Measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF)
J Headache Pain
(2005) The International Classification of Headache Disorders: 2nd Edition
Cephalalgia
(2004)- et al.
Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres
Cephalalgia
(2004) - et al.
Prevalence of migraine on each day of the natural menstrual cycle
Neurology
(2004) - et al.
Coronary side-effect potential of current and prospective antimigraine drugs
Circulation
(1998) Practice parameter: Evidence-based guidelines for migraine headache (an evidencebased review): Report of the Quality Standards Subcommittee for the American Academy of Neurology
Neurology
(2000)
Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy
Drugs
(2000)
Coronary vasoconstrictor potential of triptans: A review of in vitro pharmacologic data
Headache
(2004)
Cardiac arrest following use of sumatriptan
Neurology
(1995)
Oral sumatriptanassociated transmural myocardial infarction
Neurology
(1995)
Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan
Intensive Care Med
(1995)
Frova (frovatriptan succinate) [prescribing information]
(2007)
Zomig, Zomig-ZMT (zolmitriptan) [prescribing information]
(2007)
Amerge (naratriptan hydrochloride) [prescribing information]
(2007)
Migraine frequency and risk of cardiovascular disease in women
Neurology
(2009)
Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebocontrolled, two-period crossover, single-centre study in healthy female volunteers
Clin Drug Investig
(2009)
Patterns of use of triptans and reasons for switching them in a tertiary care migraine population
Headache
(2004)
Acute migraine therapy: Do doctors know what migraine patients want from therapy?
Headache
(1999)
Triptans (serotonin,5-HT1 B/1 Dagonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials
Cephalalgia
(2002)
Satisfaction with current migraine therapy: Experience from 3 centers in US and Sweden
Headache
(2007)
Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan
Headache
(2006)
Clinical efficacy of frovatriptan: Placebo-controlled studies
Headache
(2002)
Tolerability and safety of frovatriptan with short- and longterm use for treatment of migraine and in compari son with sumatriptan
Headache
(2002)
Clinical pharmacokinetics of frovatriptan
Headache
(2002)
Migraine headache recurrence: Relationship to clinical, pharmacological, and pharmacokinetic properties of triptans
Headache
(2003)
Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coro nary arteries
J Cardiovasc Pharmacol
(1998)
Cited by (0)
Copyright © 2010 Excerpta Medica Inc. All rights reserved.